Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP219263.RAqK-FHz8YlzXEyPFksXmpdig0mpC9YW6Tfi5SdC0Klgc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP219263.RAqK-FHz8YlzXEyPFksXmpdig0mpC9YW6Tfi5SdC0Klgc130_assertion type Assertion NP219263.RAqK-FHz8YlzXEyPFksXmpdig0mpC9YW6Tfi5SdC0Klgc130_head.
- NP219263.RAqK-FHz8YlzXEyPFksXmpdig0mpC9YW6Tfi5SdC0Klgc130_assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219263.RAqK-FHz8YlzXEyPFksXmpdig0mpC9YW6Tfi5SdC0Klgc130_provenance.
- NP219263.RAqK-FHz8YlzXEyPFksXmpdig0mpC9YW6Tfi5SdC0Klgc130_assertion evidence source_evidence_literature NP219263.RAqK-FHz8YlzXEyPFksXmpdig0mpC9YW6Tfi5SdC0Klgc130_provenance.
- NP219263.RAqK-FHz8YlzXEyPFksXmpdig0mpC9YW6Tfi5SdC0Klgc130_assertion SIO_000772 22334453 NP219263.RAqK-FHz8YlzXEyPFksXmpdig0mpC9YW6Tfi5SdC0Klgc130_provenance.
- NP219263.RAqK-FHz8YlzXEyPFksXmpdig0mpC9YW6Tfi5SdC0Klgc130_assertion wasDerivedFrom befree-20140225 NP219263.RAqK-FHz8YlzXEyPFksXmpdig0mpC9YW6Tfi5SdC0Klgc130_provenance.
- NP219263.RAqK-FHz8YlzXEyPFksXmpdig0mpC9YW6Tfi5SdC0Klgc130_assertion wasGeneratedBy ECO_0000203 NP219263.RAqK-FHz8YlzXEyPFksXmpdig0mpC9YW6Tfi5SdC0Klgc130_provenance.